How to Value an Internal Medicine Practice in 2026

Internal medicine is one of the hardest specialties to value, and I'll tell you why upfront: your single biggest "buyer" isn't a buyer at all. It's the local health system offering you a W-2 employment contract. Every valuation conversation with an internist eventually runs into the same question — "why would I sell the practice when Ascension or HCA will just hire me for $280K and take the headache away?"

That alternative sets the ceiling on what your practice is actually worth. Let me walk through how internal medicine practices get valued in 2026, where the real money is hiding, and why the practices fetching 6x EBITDA look very different from the ones stuck at 3x.

The 3-6x EBITDA Range (and Why It's So Wide)

Internal medicine practices trade in a 3-6x EBITDA band, and the range isn't arbitrary. At the low end you have a 55-year-old solo internist with 1,400 patients, a fee-for-service PPO mix, no associate, and a lease that expires in 18 months. At the high end you have a three-provider group with 6,500 attributed lives in an MSSP ACO, 40% of revenue coming from capitated Medicare Advantage contracts, and a nurse practitioner handling chronic care management billing. Same specialty, completely different businesses.

Private equity-backed primary care platforms — VillageMD (Walgreens), Oak Street Health (CVS/Aetna), ChenMed, Agilon, and Privia — pay at the top of the range when your practice fits their model. If you're traditional fee-for-service with no risk-bearing contracts, you're not their buyer, and you're stuck with local physician buyers who value your practice on SDE at 2-3x.

Panel Size Is the Asset, Not the P&L

For sophisticated buyers, your financials matter less than your patient panel. A "panel" is the count of patients who consider you their primary care physician — typically defined as anyone seen in the last 18-24 months. The numbers I watch:

• Under 1,200 patients per provider: the practice looks thin. Buyers assume you're either winding down or losing patients to competitors.
• 1,500-1,800 per provider: the industry benchmark. Healthy utilization, room to grow.
• 2,000+ per provider: either you're underserving patients (buyer risk) or you have strong retention and extender staff (buyer opportunity).
• Medicare mix above 40%: this is where the value-based care buyers get interested, because Medicare Advantage economics only work with scale in seniors.

I've seen two practices with identical $1.4M revenue get offers $600K apart because one had 4,200 active patients and the other had 2,100. The buyer wasn't paying for this year's income — they were paying for next year's capitation contract.

Value-Based Care Contracts Change Everything

If your practice participates in a Medicare Shared Savings Program (MSSP) ACO, has direct Medicare Advantage capitation arrangements, or is contracted with a value-based enabler like Aledade, Agilon, or Privia, you are in a completely different valuation universe than a straight fee-for-service practice.

Here's the math. A fee-for-service internist might generate $220 per Medicare patient per year in office-visit revenue. That same patient under a full-risk Medicare Advantage capitation contract can generate $1,200-$2,400 per year in shared savings and care-management fees if the practice manages total cost of care well. Buyers aren't valuing the current P&L — they're valuing what the panel becomes once it's moved onto their risk contracts.

This is why Agilon Health paid what it did for primary care groups in Texas and Pennsylvania, and why Walgreens bought a majority stake in VillageMD at a valuation that looked insane relative to traditional metrics. The multiple on EBITDA wasn't the point. The multiple on attributed senior lives was.

The Hospital Employment Alternative

Before you hire a broker, run this exercise. Call the physician recruiter at your two biggest local health systems and ask what they'd pay to bring you on as an employed physician, including a sign-on bonus and any practice asset purchase.

In most markets in 2026, a mid-career internist with a healthy panel gets offered $240-$320K base salary plus $30-75K sign-on, plus the health system buys the practice assets (equipment, EHR, minimal goodwill) for book value. The total package at NPV often exceeds what a private equity buyer would pay, and you walk away from the real estate decision, the billing headaches, and the staff management.

This matters for valuation because it sets your opportunity cost. If the hospital offer nets you $1.8M in present-value compensation over five years and a PE buyer offers $900K for your practice plus a $220K employment contract, the hospital path wins. I've watched physicians reject 5x EBITDA offers because the employment math was simply better — and they were right.

What Destroys Internal Medicine Value

Solo provider with no extenders. If it's just you and a receptionist, your practice effectively dies when you stop practicing. No buyer will pay real goodwill for a practice that can't survive the seller's departure. Having a nurse practitioner or PA who sees 40-50% of the volume doubles your exit options.

No chronic care management or annual wellness visit billing. These CMS codes (CCM, TCM, AWV, RPM) are free money for practices that run them correctly — $60-$120 per patient per month on top of E&M revenue. If you're not billing them, you're signaling operational weakness, and buyers discount accordingly.

Fee-for-service only in a Medicare-heavy panel. If 50% of your patients are 65+ and you're not in at least an upside-only ACO, you're leaving enormous money on the table and any sophisticated buyer will notice.

EHR chaos. Still on a legacy system or running paper charts in 2026? That's a $75K-$150K integration problem the buyer will deduct from their offer, plus the six-month productivity hit during conversion.

How to Maximize Value Before Selling

If you're 18-36 months from exit, these are the moves that actually change your valuation outcome:

Get into an ACO now. Joining an Aledade- or Privia-affiliated ACO takes 6-12 months to show results, and buyers want to see at least one full performance year of shared-savings data. Starting late is worse than not starting at all.

Hire a nurse practitioner. A mid-level provider earning $125K who generates $380K in collections adds $100-250K to your enterprise value on exit and proves the practice isn't a one-doctor show.

Bill CCM and AWV on every eligible patient. A 1,500-patient Medicare panel fully enrolled in chronic care management adds $180K of high-margin recurring revenue. That flows almost entirely to EBITDA and multiplies at 4-6x.

Clean your adjusted EBITDA story. Separate your owner compensation clearly, document personal expenses running through the practice, and get a reviewed P&L for the trailing three years. Buyers and their lenders need to trust the numbers.

The Bottom Line

Internal medicine practices in 2026 are valued by who's buying, not what the spreadsheet says. A traditional fee-for-service practice sold to another physician trades at 2-3x SDE. The same practice with value-based contracts, a senior-heavy panel, and extender staff can fetch 5-6x EBITDA from a VillageMD or Agilon-backed platform. The difference is typically $800K to $2M on a mid-sized practice — and the work to get there takes 18-24 months. If you're thinking about selling, start now.